These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24881782)

  • 21. Using host defenses to fight infectious diseases.
    Kelley KJ
    Nat Biotechnol; 1996 May; 14(5):587-90. PubMed ID: 9630947
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monoclonal antibodies for treating infectious diseases].
    Klinguer-Hamour C; Caussanel V; Beck A
    Med Sci (Paris); 2009 Dec; 25(12):1116-20. PubMed ID: 20035689
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antimicrobial chemoprophylaxis in immunocompromised patients.
    Frøland SS
    Scand J Infect Dis Suppl; 1990; 70():130-40. PubMed ID: 2287895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of antimicrobial peptides in host defense against mycobacterial infections.
    Méndez-Samperio P
    Peptides; 2008 Oct; 29(10):1836-41. PubMed ID: 18582513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Current problems of antibacterial therapy].
    Ludwig E
    Orv Hetil; 1998 Sep; 139(37):2179-84. PubMed ID: 9769686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Killer peptide: a novel paradigm of antimicrobial, antiviral and immunomodulatory auto-delivering drugs.
    Magliani W; Conti S; Ciociola T; Giovati L; Zanello PP; Pertinhez T; Spisni A; Polonelli L
    Future Med Chem; 2011 Jul; 3(9):1209-31. PubMed ID: 21806382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human microbial ecology: lactobacilli, probiotics, selective decontamination.
    Mikelsaar M
    Anaerobe; 2011 Dec; 17(6):463-7. PubMed ID: 21787875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IMAP 2012: Antimicrobial peptides to combat (multi)drug-resistant pathogens.
    Adermann K; Hoffmann R; Otvos L
    Protein Pept Lett; 2014 Apr; 21(4):319-20. PubMed ID: 24164271
    [No Abstract]   [Full Text] [Related]  

  • 29. The evolution of fluorinated quinolones: pharmacology, microbiological activity, clinical uses, and toxicities.
    Siporin C
    Annu Rev Microbiol; 1989; 43():601-27. PubMed ID: 2679364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Probiotics--an alternative for antibiotics?].
    Trafalska E; Grzybowska K
    Wiad Lek; 2004; 57(9-10):491-8. PubMed ID: 15765768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A polyalanine peptide derived from polar fish with anti-infectious activities.
    Cardoso MH; Ribeiro SM; Nolasco DO; de la Fuente-Núñez C; Felício MR; Gonçalves S; Matos CO; Liao LM; Santos NC; Hancock RE; Franco OL; Migliolo L
    Sci Rep; 2016 Feb; 6():21385. PubMed ID: 26916401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
    Hörmannsperger G; Haller D
    Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy.
    Mego M; Holec V; Drgona L; Hainova K; Ciernikova S; Zajac V
    Complement Ther Med; 2013 Dec; 21(6):712-23. PubMed ID: 24280481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammalian antimicrobial proteins and peptides: overview on the RNase A superfamily members involved in innate host defence.
    Boix E; Nogués MV
    Mol Biosyst; 2007 May; 3(5):317-35. PubMed ID: 17460791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Currently available antimicrobial agents and their potential for use as monotherapy.
    Peterson LR
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():30-45. PubMed ID: 19040464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunomodulators as adjuvants for vaccines and antimicrobial therapy.
    Nicholls EF; Madera L; Hancock RE
    Ann N Y Acad Sci; 2010 Dec; 1213():46-61. PubMed ID: 20946578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probiotics.
    Gupta V; Garg R
    Indian J Med Microbiol; 2009; 27(3):202-9. PubMed ID: 19584499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The therapeutic effect of probiotic bacteria on gastrointestinal diseases.
    Sarowska J; Choroszy-Król I; Regulska-Ilow B; Frej-Mądrzak M; Jama-Kmiecik A
    Adv Clin Exp Med; 2013; 22(5):759-66. PubMed ID: 24285463
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New insights into the bioactivity of peptides from probiotics.
    Mandal SM; Pati BR; Chakraborty R; Franco OL
    Front Biosci (Elite Ed); 2016 Jun; 8(3):450-9. PubMed ID: 27100351
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Towards understanding molecular modes of probiotic action.
    Marco ML; Pavan S; Kleerebezem M
    Curr Opin Biotechnol; 2006 Apr; 17(2):204-10. PubMed ID: 16510275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.